OpenURL Connection Search

Select item for more details and to access through your institution.

Bioavailability and Bloequivalence.
Published in:
Journal of Clinical Pharmacology, 1976, v. 16, n. 10, p. 539, doi. 10.1177/009127007601601013
By:
- Skelly, Jerome P.
Publication type:
Article
Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development.
Published in:
Clinical Pharmacology & Therapeutics, 1992, v. 51, n. 4, p. 465, doi. 10.1038/clpt.1992.47
By:
- Peck, Carl C;
- Barr, William H;
- Benet, Leslie Z;
- Collins, Jerry;
- Desjardins, Robert E;
- Furst, Daniel E;
- Harter, John G;
- Levy, Gerhard;
- Ludden, Thomas;
- Rodman, John H;
- Sanathana, Lilly;
- Schentag, Jerome J;
- Shah, Vinod P;
- Sheiner, Lewis B;
- Skelly, Jerome P;
- Stanski, Donald R;
- Temple, Robert J;
- Viswanathan, C T;
- Weissinger, Judi;
- Yacobi, Avraham
Publication type:
Article
High performance liquid chromatographic analysis of six conjugated and unconjugated estrogens in serum.
Published in:
Biomedical Chromatography, 1992, v. 6, n. 6, p. 265, doi. 10.1002/bmc.1130060604
By:
- Su, Syang Y.;
- Shiu, Gerald K.;
- Simmons, John;
- Viswanathan, C. T.;
- Skelly, Jerome P.
Publication type:
Article
Opportunities for Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development.
Published in:
1994
By:
- Peck, Carl C.;
- Barr, William H.;
- Benet, Leslie Z.;
- Collins, Jerry;
- Desjardins, Robert E.;
- Furst, Daniel E.;
- Harter, John G.;
- Levy, Gerhard;
- Ludden, Thomas;
- Rodman, John H.;
- Sanathanan, Lilly;
- Schentag, Jerome J.;
- Shah, Vinod P.;
- Sheiner, Lewis B.;
- Skelly, Jerome P.;
- Stanski, Donald R.;
- Temple, Robert J.;
- Viswanathan, C. T.;
- Weissinger, Judi;
- Yacobi, Avraham
Publication type:
Other

Found: 4

Bioavailability and Bloequivalence.

Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development.

High performance liquid chromatographic analysis of six conjugated and unconjugated estrogens in serum.

Opportunities for Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development.